Anti-Cdc25A (phospho S178) antibody
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Polyclonal Cdc25A phospho S178 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human M-phase inducer phosphatase 1 phospho S178.
View Alternative Names
M-phase inducer phosphatase 1, Dual specificity phosphatase Cdc25A, CDC25A
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cdc25A (phospho S178) antibody (AB79252)
Left panel : immunohistochemistry analysis of paraffin-embedded Human breast carcinoma tissue using 1/50 ab79252. Right panel : same, after pre-incubation with the immunizing peptide.
- WB
Unknown
Western blot - Anti-Cdc25A (phospho S178) antibody (AB79252)
All lanes:
Western blot - Anti-Cdc25A (phospho S178) antibody (ab79252) at 1/500 dilution
Lane 1:
Extracts from A549 cell treated with UV (15mins) at 30 µg
Lane 2:
Extracts from A549 cell treated with UV (15mins) at 30 µg with immunizing phosphopeptide
Predicted band size: 59 kDa
Observed band size: 110 kDa,117 kDa,59 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cdc25A plays a big role in controlling transitions between cell cycle phases particularly the G1 to S phase. It participates in a CDK complex which includes partners like Cyclin E and Cyclin A driving progression through cell cycle checkpoints. During DNA replication Cdc25A's activity ensures that cells duplicate accurately maintaining genome integrity and balance in cell proliferation.
Pathways
Cdc25A functions within the cell cycle regulation and DNA damage repair pathways. It interacts importantly with proteins like Checkpoint Kinase 1 and 2 (Chk1/Chk2) involved in responding to DNA damage. During adverse conditions Chk1/Chk2 phosphorylate Cdc25A leading to its degradation and preventing further cycle progression. This mechanism helps maintain genomic stability by halting the cycle until DNA repair occurs.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 14:1124240 PubMed36874033
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:571-582 PubMed32468021
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:14059 PubMed28094252
2017
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com